Abstract
Background Burkitt lymphoma (BL) is one of the most common childhood cancers in sub-Saharan Africa and aetiologically linked to malaria. However, evidence for an effect of malaria interventions on BL is limited. The aim of this study was to investigate the potential population-level association between large-scale rollout of insecticide-treated bednets (ITNs) in sub-Saharan Africa in the 2000s and BL incidence.
Methods We conducted a systematic review in Embase, Global Health and MEDLINE to assemble all available data on BL incidence rates in children aged 0-15 years in malaria-endemic sub-Saharan African countries between Jan 1, 1990 and Feb 27, 2023. We calculated pooled estimates of BL incidence in sub-Saharan Africa for the time periods before and after ITN introduction. We used model estimates of sub-national ITN use to assess the association between average population ITN use and childhood BL incidence rates in a negative binomial regression model.
Results We included 23 studies comprising 66 datapoints on BL incidence based on 5,226 cancer cases from locations with large-scale ITN use in 17 countries. BL rates were 44% (95% CI 12-64%) lower in the time period after ITN introduction compared to before. The pooled incidence rate of BL was 1.36 (95% CI 0.88-2.10) and 0.76 (95% CI 0.50-1.16) per 100,000 person-years before and after introduction of ITNs, respectively. After adjusting for potential confounders, a 1% increase in average ITN use in the population in the 10 years before BL data collection was associated with a 2% (95% CI 1-4%) reduction in BL incidence.
Conclusion These findings suggest that large-scale rollout of ITNs in the 2000s was associated with a reduction in childhood BL burden in sub-Saharan Africa. Although published data may not be representative of all incidence rates across sub-Saharan Africa, our study highlights a potential additional benefit of malaria control programmes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NS acknowledges funding from a Wellcome Trust grant awarded to Prof Azra Ghani and Prof Katharina Hauck [reference 220900/Z/20/Z] and from the MRC Centre for Global Infectious Disease Analysis [reference MR/R015600/1], jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. EKA is supported by a Cancer Research UK (CRUK) grant awarded to Dr Tsilidis K [reference PPRCPJT\100005] and acknowledges funding from a return grant from the International Agency for Research on Cancer-World Health Organization (IARC-WHO). For the purpose of open access, the authors have applied a Creative Commons Attribution (CC BY) license to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
All data reported in this study were extracted from published studies. All covariate estimates used in the analysis are publicly available from the sources cited in the article.
